Balance Sheet The Carlyle Group Inc.
Equities
CG
US14316J1088
Investment Management & Fund Operators
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
52.48 USD | -0.18% |
|
-7.09% | +3.62% |
Feb. 03 | Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group | MT |
Jan. 31 | Shareholder activists demand clear strategy from thyssenkrupp CEO | RE |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 916M | 1.14B | 2.62B | 1.57B | 1.79B | |||||
Accounts Receivable, Total | 4.12B | 5.22B | 8.49B | 7.66B | 6.48B | |||||
Other Receivables | 84.9M | 107M | 164M | 143M | 185M | |||||
Net Property Plant And Equipment | 312M | 510M | 505M | 477M | 494M | |||||
Goodwill | 16.1M | 16.8M | 13.3M | 104M | 104M | |||||
Other Intangibles, Total | 46.2M | 31.9M | 21.6M | 794M | 662M | |||||
Investment In Debt and Equity Securities | 5.51B | 6.66B | 7.23B | 7.62B | 8.01B | |||||
Trading Asset Securities, Total | - | - | - | 20M | - | |||||
Restricted Cash | 34.6M | 2M | 5.6M | 800K | 1.8M | |||||
Other Current Assets, Total | 54M | 51.7M | 61.7M | - | 335M | |||||
Deferred Tax Assets Long-Term (Collected) | 270M | 96.5M | 14.5M | 15.8M | 16.5M | |||||
Other Long-Term Assets, Total | 2.44B | 1.81B | 2.13B | 3B | 3.09B | |||||
Total Assets | 13.81B | 15.64B | 21.25B | 21.4B | 21.18B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 340M | 262M | 256M | 290M | 245M | |||||
Accrued Expenses, Total | 2.48B | 3.2B | 4.95B | 4.23B | 4.91B | |||||
Current Portion of Long-Term Debt | - | - | - | - | - | |||||
Current Portion of Leases | 56.9M | 47.8M | 65.2M | 68.1M | 66.9M | |||||
Long-Term Debt | 6.68B | 7.53B | 7.96B | 8.18B | 8.77B | |||||
Long-Term Leases | 231M | 466M | 473M | 435M | 421M | |||||
Current Income Taxes Payable | - | - | 93.3M | 39.7M | 46.9M | |||||
Other Current Liabilities - (Brok / FS / Ins. / REIT Template) | 31.4M | 50.6M | 6.3M | 76.5M | 2.5M | |||||
Unearned Revenue Non Current | 71M | 89M | 121M | 126M | 140M | |||||
Pension & Other Post Retirement Benefits | - | - | 27.4M | 9.5M | 13.1M | |||||
Deferred Tax Liability Non-Current | 65.2M | 57.8M | 487M | 403M | 45.3M | |||||
Other Non Current Liabilities | 880M | 1.01B | 1.1B | 722M | 737M | |||||
Total Liabilities | 10.84B | 12.71B | 15.54B | 14.58B | 15.39B | |||||
Preferred Stock Redeemable | - | - | - | - | - | |||||
Total Preferred Equity | - | - | - | - | - | |||||
Common Stock, Total | 704M | 3.5M | 3.6M | 3.6M | 3.6M | |||||
Additional Paid In Capital | - | 2.55B | 2.72B | 3.14B | 3.4B | |||||
Retained Earnings | - | 348M | 2.81B | 3.4B | 2.08B | |||||
Comprehensive Income and Other | -85.2M | -209M | -248M | -322M | -297M | |||||
Total Common Equity | 619M | 2.69B | 5.28B | 6.22B | 5.19B | |||||
Minority Interest | 2.35B | 241M | 427M | 600M | 593M | |||||
Total Equity | 2.97B | 2.93B | 5.71B | 6.82B | 5.78B | |||||
Total Liabilities And Equity | 13.81B | 15.64B | 21.25B | 21.4B | 21.18B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 348M | 354M | 356M | 364M | 362M | |||||
ECS Total Common Shares Outstanding | 118M | 354M | 355M | 362M | 361M | |||||
Book Value / Share | 5.25 | 7.61 | 14.86 | 17.17 | 14.37 | |||||
Tangible Book Value | 556M | 2.64B | 5.24B | 5.32B | 4.43B | |||||
Tangible Book Value Per Share | 4.72 | 7.47 | 14.76 | 14.69 | 12.25 | |||||
Total Debt | 6.97B | 8.05B | 8.5B | 8.68B | 9.26B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 27.8M | 41.8M | 27.4M | 9.5M | 13.1M | |||||
Net Debt | 6.06B | 6.91B | 5.88B | 7.09B | 7.47B | |||||
Equity Method Investments, Total | 2.44B | 1.81B | 2.13B | 2.92B | 3.02B | |||||
Full Time Employees | 1.78K | 1.82K | 1.85K | 2.1K | 2.2K |